Hosted on MSN

More support for omitting lymph node biopsy in low-risk early breast cancer

SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested. After 5 years, the regional recurrence-free survival ...
EurekAlert!

Moffitt study shows gene expression test can help identify melanoma patients at low risk of lymph node spread

TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...
ascopubs.org

Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer

Invasion Factors uPA/PAI-1 and HER2 Status Provide Independent and Complementary Information on Patient Outcome in Node-Negative Breast Cancer Purpose: We postulate that surgical sampling and ...
Nasdaq

New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity

Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...
MedPage Today on MSN

New emphasis on N1 lymph nodes dawns on lung resections

Observational study finds more pathologic nodal upstaging with more nodes sampled ...